[The place for therapeutic intensification in small cell lung cancer].

Abstract

Therapeutic intensification of small cell lung cancer (SCLC) relies on either the simultaneous and repeated administration of a greater number of drugs without cross-resistance, or to the use of classical combinations with greater intensity, either by increasing the doses in each cycle or by reducing the intervals between cycles. The authors review the… (More)

Topics

Cite this paper

@article{Corne2004ThePF, title={[The place for therapeutic intensification in small cell lung cancer].}, author={F Corne and Luc Thiberville}, journal={Revue de pneumologie clinique}, year={2004}, volume={60 5 Pt 2}, pages={3S104-9} }